SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sertic D)
 

Sökning: WFRF:(Sertic D) > The EUTOS populatio...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003640naa a2200661 4500
001oai:DiVA.org:uu-257017
003SwePub
008150629s2015 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2570172 URI
024a https://doi.org/10.1038/leu.2015.732 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Hoffmann, V. S.4 aut
2451 0a The EUTOS population-based registry :b incidence and clinical characteristics of 2904 CML patients in 20 European Countries
264 c 2015-03-18
264 1b Springer Science and Business Media LLC,c 2015
338 a print2 rdacarrier
520 a This population-based registry was designed to provide robust and updated information on the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of newly diagnosed Philadelphia positive, BCR-ABL1+ CML that occurred in a sample of 92.5 million adults living in 20 European countries, were registered over a median period of 39 months. 94.3% of the 2904 CML patients were diagnosed in chronic phase (CP). Median age was 56 years. 55.5% of patients had comorbidities, mainly cardiovascular (41.9%). High-risk patients were 24.7% by Sokal, 10.8% by EURO, and 11.8% by EUTOS risk scores. The raw incidence increased with age from 0.39/100 000/year in people 20-29 years old to 1.52 in those >70 years old, and showed a maximum of 1.39 in Italy and a minimum of 0.69 in Poland (all countries together: 0.99). The proportion of Sokal and Euro score high-risk patients seen in many countries indicates that trial patients were not a positive selection. Thus from a clinical point of view the results of most trials can be generalized to most countries. The incidences observed among European countries did not differ substantially. The estimated number of new CML cases per year in Europe is about 6370.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
700a Baccarani, M.4 aut
700a Hasford, J.4 aut
700a Lindoerfer, D.4 aut
700a Burgstaller, S.4 aut
700a Sertic, D.4 aut
700a Costeas, P.4 aut
700a Mayer, J.4 aut
700a Indrak, K.4 aut
700a Everaus, H.4 aut
700a Koskenvesa, P.4 aut
700a Guilhot, J.4 aut
700a Schubert-Fritschle, G.4 aut
700a Castagnetti, F.4 aut
700a Di Raimondo, F.4 aut
700a Lejniece, S.4 aut
700a Griskevicius, L.4 aut
700a Thielen, N.4 aut
700a Sacha, T.4 aut
700a Hellmann, A.4 aut
700a Turkina, A. G.4 aut
700a Zaritskey, A.4 aut
700a Bogdanovic, A.4 aut
700a Sninska, Z.4 aut
700a Zupan, I.4 aut
700a Steegmann, J-L4 aut
700a Simonsson, Bengtu Uppsala universitet,Hematologi4 aut0 (Swepub:uu)bengtss
700a Clark, R. E.4 aut
700a Covelli, A.4 aut
700a Guidi, G.4 aut
700a Hehlmann, R.4 aut
710a Uppsala universitetb Hematologi4 org
773t Leukemiad : Springer Science and Business Media LLCg 29:6, s. 1336-1343q 29:6<1336-1343x 0887-6924x 1476-5551
856u https://cris.unibo.it/bitstream/11585/531881/2/Hoffmann_2015.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-257017
8564 8u https://doi.org/10.1038/leu.2015.73

Hitta via bibliotek

  • Leukemia (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy